Efficacy of immunosorption in patients with systemic lupus erythematosus: A double blind controlled trial

被引:0
|
作者
Amosova, EN [1 ]
Yaremenko, OB [1 ]
Snezhkova, EA [1 ]
Drannik, GV [1 ]
机构
[1] AA Bogomolets Natl Med Univ, Chair Hosp Therapy 1, Kiev, Ukraine
关键词
SLE; immunosorption; lupus nephritis; combined therapy; immune status;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Efficacy of immunosorption (IS) employing perfusion of whole blood through activated charcoal containing DNA was studied in 11 patients with systemic lupus erythematosus (SLE). 11 SLE patients exposed to hemosorption on charcoal free from DNA served as controls. When used in combination with intensive therapy (corticosteroids and cytostatic immunosuppressant), IS produced a positive effect on lupus nephritis symptoms in 8 out of 10 patients with kidney affection. AntiDNA antibodies blood level decreased by 53.6% after two IS procedures, while only by 36.4% after nonselective hemosorption. Reduced count and functional activity of B-cells recorded after IS contribute much to final outcome of the treatment.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 50 条
  • [31] Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
    Wu, Di
    Li, Jing
    Xu, Dong
    Merrill, Joan T.
    van Vollenhoven, Ronald F.
    Liu, Yi
    Hu, Jiankang
    Li, Yang
    Li, Fen
    Huang, Chenghui
    Wang, Guochun
    Li, Xiaomei
    Zhao, Jianhong
    Zhao, Dongbao
    Huang, Cibo
    Liu, Huaxiang
    Wei, Wei
    Shi, Guixiu
    Lu, Fuai
    Zuo, Xiaoxia
    Bi, Liqi
    Li, Zhijun
    Wang, Xiaoxia
    Zhang, Miaojia
    Tie, Ning
    Li, Juan
    Mo, Hanyou
    Fang, Jianmin
    Bao, Chunde
    Zhang, Fengchun
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 475 - 487
  • [32] A Double-Blind Randomized Placebo-Controlled Trial of the Effect of Vitamin D3 On the Interferon Signature in Patients with Systemic Lupus Erythematosus
    Aranow, Cynthia
    Dall'Era, Maria
    Massarotti, Elena M.
    Mackay, Meggan C.
    Coca, Andreea
    Koumpouras, Fotios
    Levesque, Marc C.
    Chatham, W. Winn
    Clowse, Megan E. B.
    Criscione-Schreiber, Lisa G.
    Callahan, Sherri
    Goldmuntz, Ellen A.
    Keyes-Elstein, Lynette
    Diamond, Betty
    Kamen, Diane L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1110 - S1110
  • [33] Raloxifene for postmenopausal patients with systemic lupus erythematosus (SLE): A randomized controlled trial
    Mok, CC
    Mak, A
    To, CH
    Ma, KM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S196 - S197
  • [34] Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China
    Le Zhang
    Shikai Geng
    Liping Qian
    Shuang Ye
    Xiaodong Wang
    Guohong Lu
    Yang Ding
    Ting Li
    International Journal of Clinical Pharmacy, 2019, 41 : 1247 - 1255
  • [35] Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China
    Zhang, Le
    Geng, Shikai
    Qian, Liping
    Ye, Shuang
    Wang, Xiaodong
    Lu, Guohong
    Ding, Yang
    Li, Ting
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (05) : 1247 - 1255
  • [36] Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: A multicenter, randomized, double-blind, vehicle-controlled trial
    Kuhn, Annegret
    Gensch, Kristina
    Haust, Merle
    Schneider, Stefan W.
    Bonsmann, Gisela
    Gaebelein-Wissing, Noemi
    Lehmann, Percy
    Wons, Annette
    Reitmeir, Peter
    Ruland, Vincent
    Luger, Thomas A.
    Ruzicka, Thomas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (01) : 54 - 64
  • [37] Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus
    Tam, LS
    Li, EK
    Wong, CK
    Lam, CWK
    Szeto, CC
    LUPUS, 2004, 13 (08) : 601 - 604
  • [38] Bromocriptine in systemic lupus erythematosus: A double-blind, randomized placebo-controlled study.
    AlvarezNemegyei, J
    CovarrubiasCobos, A
    EscalanteTriay, F
    SosaMunoz, G
    Jara, LJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1351 - 1351
  • [39] Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial
    Fatemi, Alimohammad
    Moosavi, Mahdi
    Sayedbonakdar, Zahra
    Farajzadegan, Ziba
    Kazemi, Mehdi
    Smiley, Abbas
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1273 - 1278
  • [40] Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial
    Alimohammad Fatemi
    Mahdi Moosavi
    Zahra Sayedbonakdar
    Ziba Farajzadegan
    Mehdi Kazemi
    Abbas Smiley
    Clinical Rheumatology, 2014, 33 : 1273 - 1278